Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lisa Barisciano

Allergy & Immunology Florham Park, NJ Medical Doctor

NPI 1265401699 CMS profile 147425

15 James Street, Florham Park, NJ 09732

Open in the dashboard

General payments

$77,829

358 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Lisa Barisciano of Florham Park, NJ is reported in the CMS Open Payments database as having received $77,829 across 358 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Allergy & Immunology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $46,034 97
2024 General $20,368 98
2023 General $4,049 50
2022 General $3,582 54
2021 General $2,934 36
2020 General $543 13
2019 General $321 10

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lisa Barisciano
  • Allergy & Immunology median
  • Middle half of Allergy & Immunology
  • National median

In program year 2025, general payments to Lisa Barisciano were reported at $46,034. Among 2,466 Allergy & Immunology profiles paid that year, the median was $1,140 and the middle half received between $272 and $2,892.

Show as a table
Year Lisa Barisciano Allergy & Immunology median Middle half National median
2019 $321 $594 $163–$1,512 $163
2020 $543 $426 $106–$1,233 $114
2021 $2,934 $638 $157–$1,708 $132
2022 $3,582 $790 $205–$1,961 $149
2023 $4,049 $852 $220–$2,147 $160
2024 $20,368 $865 $203–$2,267 $164
2025 $46,034 $1,140 $272–$2,892 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. ARS Pharmaceuticals Operations, Inc. $22,731 34 payments
  2. OptiNose US, Inc. $21,038 45 payments
  3. CSL Behring $5,379 21 payments
  4. Genzyme Corporation $4,865 95 payments
  5. Novartis Pharmaceuticals Corporation $4,022 10 payments
  6. kaleo, Inc. $3,592 3 payments
  7. Grifols USA, LLC $2,802 11 payments
  8. ALK-Abello, Inc $2,583 28 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $1,981 18 payments
  10. Dermavant Sciences, Inc. $1,884 2 payments
  11. Other $6,953 91 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $37,565 22 payments
  2. Consulting Fee $18,853 14 payments
  3. Food and Beverage $14,887 298 payments
  4. Travel and Lodging $4,937 15 payments
  5. Honoraria $1,200 1 payment
  6. Education $388 8 payments
Products named General payments · program years 2019–2025
  1. NEFFY $22,731 34 payments
  2. Xhance $21,038 45 payments
  3. Andembry $4,829 7 payments
  4. DUPIXENT $4,098 148 payments
  5. AUVI-Q $3,592 3 payments
  6. Xembify $2,802 11 payments
  7. VTAMA $1,884 2 payments
  8. NUCALA $1,298 18 payments
  9. Sajazir $1,120 1 payment
  10. TEZSPIRE $693 11 payments
  11. Other $4,816 115 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

358 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Allergy & Immunology in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record